Rexahn Pharma (RNN) – Analyst Ratings
-
Brookline Capital Markets Starts Rexahn Pharmaceuticals Inc. (RNN) at Buy
-
UPDATE: IFS Securities Upgrades Rexahn Pharmaceuticals Inc. (RNN) to Strong Buy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RNN Stock Lookup